Divis is among the largest pharmaceutical companies in India with a portfolio of 120 products across diverse therapeutic areas. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids. It is also involved in developing alternate, non-infringing processes for APIs, for the inventors to manage late life cycle and generic drug manufacturers. The Company develops carotenoids, such as Apocarotenal, Astaxanthin, Betacarotene, Canthaxanthin and Lycopene. It manufactures Fluorenylmethyloxycarbonyl (FMOC), tert-butoxycarbonyl (BOC) and Carboxybenzyl (CBZ) protected amino acids. It manufactures ligands, such as binol and binap.

Divis Lab has geographical segments include India and other countries.The Company exports its products to European and the American countries. The company has four manufacturing units and market presence across several countries. The first is an export oriented unit located at village Chippada Bheemunipatnam Mandal about 30 KM from the port city of Visakhapatnam (Andhra Pradesh) on the east coast situated on a 100-acre site. The second manufacturing unit is located at village Lingojigudem in Yadadri Bhuvanagiri District near Hyderabad (Telangana) comprises 11 multipurpose production blocks with finished product areas for APIs. The third is located at the company's Pharma SEZ at village Chippada. The fourth unit is located at village Chippda situated on a sprawling 267-acre site and is a Special Economic Zone (SEZ) Unit in Pharma Sector. The company has two subsidiaries M/s. Divi's Laboratories Europe AG in Switzerland for marketing its Nutra products and M/s. Divis Laboratories (USA) Inc. in the United States of America and to provide a greater reach to customers within these regions. Divi’s has Research Centers at Sanathnagar Hyderabad where primarily focuses on custom synthesis contract research for MNC companies as also future generics involving processes like route design route selection establishing gram scale process and structural confirmation.